What is BIAF's current stock price?

BIAF (bioAffinity Technologies, Inc.) is currently trading at $1.56 with a market cap of $7.1M.

What sector is bioAffinity Technologies, Inc. in?

bioAffinity Technologies, Inc. (BIAF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.

InvestLog

BIAF bioAffinity Technologies, Inc.

Healthcare

$1.56-3.70%ClosedMarket Cap: $7.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.92

P/S

1.25

EV/EBITDA

-0.35

DCF Value

$-281.43

FCF Yield

-153.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

22.1%

Operating Margin

-204.3%

Net Margin

-280.6%

ROE

-358.8%

ROA

-199.9%

ROIC

-229.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$1.4M	$-3.6M	$—
Q4 null	$1.6M	$-3.1M	$—
FY null	$6.2M	$-14.9M	$—
Q3 null	$1.4M	$-5.1M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Rios Robertodirector

SellThu Sep 25

Oppenheimer John J.director:

SellThu Sep 25

Zannes Timothy Pofficer: Secretary, EVP, Gen. Counsel

SellTue Jan 14

Zannes Mariadirector, officer: President & CEO

SellTue Jan 14

Reveles Xavier Trinidadofficer: Chief Operating Officer

SellTue Jan 14

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

Exchange

—

Beta

-1.19

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Peers

PBM